Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease.

about

Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease.

Item

http://www.wikidata.org/entity/Q50281421

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Taliglucerase alfa: safety and ...... children with Gaucher disease.

@en

Taliglucerase alfa: safety and ...... children with Gaucher disease.

@nl

type

Item

label

Taliglucerase alfa: safety and ...... children with Gaucher disease.

@en

Taliglucerase alfa: safety and ...... children with Gaucher disease.

@nl

prefLabel

Taliglucerase alfa: safety and ...... children with Gaucher disease.

@en

Taliglucerase alfa: safety and ...... children with Gaucher disease.

@nl

P1476

Taliglucerase alfa: safety and ...... children with Gaucher disease.

@en

P2093

Ari Zimran

http://www.w3.org/2001/XMLSchema#string

Betina Hernandez

http://www.w3.org/2001/XMLSchema#string

Gregory M Pastores

http://www.w3.org/2001/XMLSchema#string

Michael Wajnrajch

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients.

Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements.

The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.

Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.

Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease.

Management of Gaucher disease: enzyme replacement therapy.

Long-term efficacy and safety results of taliglucerase alfa through 5years in adult treatment-naïve patients with Gaucher disease.

Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy.

P2888

s13023-018-0776-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S13023-018-0776-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2018-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101169728

http://www.w3.org/2001/XMLSchema#string

P698

29471850

http://www.w3.org/2001/XMLSchema#string

P921

Anzim

Gaucher's disease

P932

5824466

http://www.w3.org/2001/XMLSchema#string